Journal Article (Review Article)

DKFZ-2019-02924

http://join2-wiki.gsi.de/foswiki/pub/Main/Artwork/join2_logo100x88.png CAR-Engineered NK Cells for the Treatment of Glioblastoma: Turning Innate Effectors Into Precision Tools for Cancer Immunotherapy.

Burger, M. C.DKFZ* ; Zhang, C.DKFZ* ; Harter, P.DKFZ* ; Romanski, A. ; Strassheimer, F. ; Senft, C.DKFZ* ; Tonn, T.DKFZ* ; Steinbach, J. P.DKFZ* ; Wels, W. S.DKFZ*

2019
Frontiers Media Lausanne

This record in other databases:  

Please use a persistent id in citations: doi:10.3389/fimmu.2019.02683

Abstract: CAR-Engineered NK Cells for the Treatment of Glioblastoma: Turning Innate Effectors Into Precision Tools for Cancer Immunotherapy.

Note: EA:L501

---

Contributing Institute(s):

1. DKTK Frankfurt (L501)
2. DKTK Dresden (L301)

Research Program(s):

1. 899 - ohne Topic (POF3-899) (POF3-899)

Appears in the scientific report 2019

---

Database coverage:
; ; ; Clarivate Analytics Master Journal List ; DOAJ Seal ; IF >= 5 ; JCR ; NCBI Molecular Biology Database ; PubMed Central ; SCOPUS ; Science Citation Index Expanded ; Web of Science Core Collection

---